Yes-Associated Protein (YAP) Facilitates Pressure Overload–Induced Dysfunction in the Diabetic Heart

Shohei Ikeda, Risa Mukai, Wataru Mizushima, Peiyong Zhai, Shin ichi Oka, Michinari Nakamura, Dominic P. Del Re, Sebastiano Sciarretta, Chiao Po Hsu, Hiroaki Shimokawa, Junichi Sadoshima

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Patients with diabetes are more prone to developing heart failure in the presence of high blood pressure than those without diabetes. Yes-associated protein (YAP), a key effector of the Hippo signaling pathway, is persistently activated in diabetic hearts, and YAP plays an essential role in mediating the exacerbation of heart failure in response to pressure overload in the hearts of mice fed a high-fat diet. YAP induced dedifferentiation of cardiomyocytes through activation of transcriptional enhancer factor 1 (TEAD1), a transcription factor. Thus, YAP and TEAD1 are promising therapeutic targets for diabetic patients with high blood pressure to prevent the development of heart failure.

Original languageEnglish (US)
Pages (from-to)611-622
Number of pages12
JournalJACC: Basic to Translational Science
Issue number5
StatePublished - Sep 2019

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


  • Hippo pathway
  • diabetes
  • diabetic cardiomyopathy
  • pressure overload


Dive into the research topics of 'Yes-Associated Protein (YAP) Facilitates Pressure Overload–Induced Dysfunction in the Diabetic Heart'. Together they form a unique fingerprint.

Cite this